Literature DB >> 12957524

Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy.

Pedro Luna-Pérez1, Saúl Rodríguez-Ramírez, Isabel Alvarado, Marcos Gutiérrez de la Barrera, Sonia Labastida.   

Abstract

BACKGROUND: Histologic examination of a regional lymphadenectomy specimen ordinarily should include 12 or more lymph nodes. However, in specimens from patients who received preoperative chemoradiotherapy this number has not yet been established.
METHODS: From January 1990 to December 2000, 210 patients with rectal adenocarcinoma located between 0 and 10 cm from anal verge with invasion into perirectal fat, tethered or fixed to the pelvis, diagnosed by computed tomography (CT) scan and/or rectal ultrasound were included. All patients received 45 Gy+bolus infusion of 5-FU (450 mg/m2/days 1-5, 28-33 of RT) 4-8 weeks after surgery was performed. Specimens were mapped and sliced. Lymph nodes were studied under clearing or manual techniques. Five-year survival was calculated by Kaplan-Meier method and comparison of groups with log-rank test. Multivariate Cox regression analysis was performed to find risk factors affecting local control and survival.
RESULTS: There were 126 males and 84 females; mean age was 55.2 years. Low anterior resection was performed in 112 patients, abdominoperineal resection in 85, and pelvic exenteration in 13. Total retrieved lymph nodes numbered 2,554, of which 252 contained metastasis. The group was divided into patients with 1-10 retrieved lymph nodes (n=119) and patients with > or = 11 retrieved lymph nodes (n=91). Median follow-up was 49 months. Local recurrence was as follows: 15% in patients with specimens containing 1-10 lymph nodes and conversely 7.4% in those with > or = 11 (p=0.01). Five-year survival of patients with 1-10 lymph nodes was 48%, whereas for those with > or = 11 lymph nodes it was 69% (p=0.02).
CONCLUSIONS: Retrieval of at least 11 lymph nodes in the surgical specimen is not only a powerful tool to properly stage patients with rectal adenocarcinoma treated with preoperative chemoradiotherapy and surgery, but it is also of prognostic relevance in that 5-year survival and local recurrence were better in this group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12957524     DOI: 10.1016/s0188-4409(03)00041-9

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  15 in total

1.  Quality management in rectal carcinoma: what is feasible?

Authors:  Susanne Merkel; Daniela Klossek; Jonas Göhl; Thomas Papadopoulos; Werner Hohenberger; Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

2.  10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer.

Authors:  Marco E Allaix; Giuseppe Giraudo; Alessia Ferrarese; Alberto Arezzo; Fabrizio Rebecchi; Mario Morino
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

3.  Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma.

Authors:  Chiaojung Jillian Tsai; Christopher H Crane; John M Skibber; Miguel A Rodriguez-Bigas; George J Chang; Barry W Feig; Cathy Eng; Sunil Krishnan; Dipen M Maru; Prajnan Das
Journal:  Cancer       Date:  2011-02-15       Impact factor: 6.860

4.  Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner.

Authors:  Yang-Chun Zheng; Yu-Ying Tang; Zong-Guang Zhou; Li Li; Tian-Cai Wang; Yi-Ling Deng; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

5.  Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer.

Authors:  Pramodh Chitral Chandrasinghe; Dileepa Senajith Ediriweera; Janaki Hewavisenthi; Sumudu Kumarage; Kemal Ismail Deen
Journal:  Indian J Gastroenterol       Date:  2013-09-19

6.  Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer.

Authors:  Nam-Kyu Kim; Young-Wan Kim; Byung-Soh Min; Kang-Young Lee; Seung-Kook Sohn; Chang-Hwan Cho
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

7.  Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer.

Authors:  E Benzoni; D Intersimone; G Terrosu; V Bresadola; A Cojutti; F Cerato; C Avellini
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

8.  Clinical impact of fat clearing technique in nodal staging of rectal cancer after preoperative chemoradiotherapy.

Authors:  Im-Kyung Kim; Beom Jin Lim; Jeonghyun Kang; Seong-Ah Kim; Dongwon Kang; Seung-Kook Sohn; Kang Young Lee
Journal:  J Korean Surg Soc       Date:  2013-06-26

9.  Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

Authors:  Thilo Sprenger; Hilka Rothe; Kia Homayounfar; Tim Beissbarth; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  J Gastrointest Surg       Date:  2009-10-15       Impact factor: 3.452

10.  The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.

Authors:  Stefano Scabini; Fabrizio Montecucco; Alessio Nencioni; Gabriele Zoppoli; Marina Sartini; Edoardo Rimini; Andrea Massobrio; Luisito De Marini; Alessandro Poggi; Roberto Boaretto; Emanuele Romairone; Alberto Ballestrero; Valter Ferrando
Journal:  World J Surg Oncol       Date:  2013-11-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.